<table class=\"Table\">
    <thead>
        <tr>
            <th>Cycle Number</th>
            <th>Pre-Treatment Phase</th>
            <th colspan=\"4\">Treatment Phase¹</th>
            <th colspan=\"2\">Post-Treatment Phase</th>
        </tr>
        <tr>
            <th></th>
            <th>Screening</th>
            <th colspan=\"4\">Cycle 1</th>
            <th>EOT</th>
            <th>1M FUP</th>
        </tr>
        <tr>
            <th>Day within Cycle Visit Window (± days)</th>
            <th>D-14 to D-1</th>
            <th>D1</th>
            <th>D8 (±2)</th>
            <th>D15 (±2)</th>
            <th>D22 (±2)</th>
            <th>≤ 10 d from the decision of trial treatment withdrawal</th>
            <th>1 month after last dose of trial treatment (28+7d)</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td>Informed Consent</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Baseline Characteristics/Eligibility²</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Safety Assessments</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Medication Survey</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>(S)AE Survey and Reporting</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>DLT Evaluation (dose-escalation only)³</td>
            <td></td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Vital Signs and Body Weight</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>ECOG PS</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Physical Examination</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Dermatological Examination</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>ECG</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Safety blood samples⁸</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Urinalysis⁸</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Pregnancy Test</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Disease Assessments</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>(Archival) Tumor Biopsy Collection⁸,⁹</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Tumor Marker Evaluation⁹</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Disease Status Evaluation by CT/ MRI⁹,¹⁰</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>*Additional Assessments</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>*PK Samples (dose-escalation only)¹¹</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>*ADA Sample</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>*Biomarker Blood and Urine Sample¹²</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Trial Treatment</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Skin Toxicity Prophylaxis and TX¹³</td>
            <td></td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Infusion Reaction Prophylaxis ¹⁴</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Sym004 Infusion</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Gastrointestinal Toxicity Prophylaxis ¹⁵</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>FOLFIRI Infusion</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Post-Infusion Monitoring</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
    </tbody>
</table>